Outcomes of Primary Vitrectomy for Rhegmatogenous Retinal Detachment With No Postoperative Positioning
- PMID: 38770069
- PMCID: PMC11102711
- DOI: 10.1177/24741264241237022
Outcomes of Primary Vitrectomy for Rhegmatogenous Retinal Detachment With No Postoperative Positioning
Abstract
Purpose: To evaluate the anatomic and visual outcomes of primary vitrectomy for rhegmatogenous retinal detachment (RRD) repair using no amount of postoperative prone positioning to clarify the role of face-down posturing for RRD reattachment. Methods: This retrospective consecutive interventional case series comprised patients who had primary vitrectomy for RRD repair. The surgical outcomes, single-surgery anatomic success rate, and postoperative best-corrected visual acuity (BCVA) were assessed. The primary objective was to evaluate the anatomic and visual outcomes of vitrectomy RRD reattachment using no postoperative prone positioning. Results: This study comprised 116 eyes of 116 patients. Single-surgery anatomic success was achieved in 112 (96.5%) of 116 eyes. The single-surgery anatomic success rate was 100% in phakic patients (n = 56) and 93% in pseudophakic patients (n = 60), with both groups having an improvement in the mean BCVA. Conclusions: Primary vitrectomy with no postoperative prone positioning is a successful surgical intervention for RRD repair. The anatomic closure rate in this study is one of the highest reported in the literature and involved a large number of macula-off RRDs, with minimal complications and a significant improvement in BCVA, primarily using 14% perfluoropropane for gas tamponade.
Keywords: postoperative positioning; retinal detachment; vitrectomy.
© The Author(s) 2024.
Conflict of interest statement
The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Dr. Almeida: Acelyrin, Alcon, Alimera Sciences, Allergan/Abbvie, Bausch + Lomb, Bayer, Boehringer Ingelheim, Citrus Therapeutics, Clinical Trials Network, EyePoint Pharmaceuticals, Inc, Genentech, Gyroscope Therapeutics, Novartos, Ocugen, Opthea, Regeneron, RegenXBio, Roche, Samsara Vision, Spherix Consulting Group. Dr. Chin: Alimera Sciences, Allergan, Bayer, Citrus Therapeutics, Genentech, Hexal AG/Sandoz Inc, Iveric Bio, Kodiak Sciences, Novartis, Opthea, Regeneron. None of the other author(s) declared potential conflicts of interest with respect to the research, authorship, and/or publication of the article.
Similar articles
-
Face-down positioning or posturing after pars plana vitrectomy for macula-involving rhegmatogenous retinal detachments.Cochrane Database Syst Rev. 2024 Mar 15;3(3):CD015514. doi: 10.1002/14651858.CD015514.pub2. Cochrane Database Syst Rev. 2024. PMID: 38488250 Free PMC article. Review.
-
Macula-On Versus Macula-Off Pseudophakic Rhegmatogenous Retinal Detachment Following Primary 23-Gauge Vitrectomy Plus Endotamponade.Curr Eye Res. 2016 Apr;41(4):543-50. doi: 10.3109/02713683.2015.1031351. Epub 2015 Jun 17. Curr Eye Res. 2016. PMID: 26082967
-
Primary Retinal Detachment Outcomes Study: Pseudophakic Retinal Detachment Outcomes: Primary Retinal Detachment Outcomes Study Report Number 3.Ophthalmology. 2020 Nov;127(11):1507-1514. doi: 10.1016/j.ophtha.2020.05.005. Epub 2020 May 8. Ophthalmology. 2020. PMID: 32437865
-
Outcomes of Pars Plana Vitrectomy Alone versus Combined Scleral Buckling plus Pars Plana Vitrectomy for Primary Retinal Detachment.Ophthalmol Retina. 2021 Feb;5(2):169-175. doi: 10.1016/j.oret.2020.09.013. Epub 2020 Sep 25. Ophthalmol Retina. 2021. PMID: 32980532
-
Management, risk factors and treatment outcomes of rhegmatogenous retinal detachment associated with giant retinal tears: scoping review.Int J Retina Vitreous. 2024 Apr 23;10(1):35. doi: 10.1186/s40942-024-00552-6. Int J Retina Vitreous. 2024. PMID: 38654369 Free PMC article.
Cited by
-
[Current trends in the treatment of rhegmatogenous retinal detachment and perioperative positioning strategies in Germany: results of a retina.net survey].Ophthalmologie. 2025 May;122(5):383-392. doi: 10.1007/s00347-025-02216-8. Epub 2025 Mar 24. Ophthalmologie. 2025. PMID: 40126653 German.
-
From the Editor-in-Chief.J Vitreoretin Dis. 2024 May 17;8(3):227-230. doi: 10.1177/24741264241245781. eCollection 2024 May-Jun. J Vitreoretin Dis. 2024. PMID: 38770065 Free PMC article. No abstract available.
References
-
- Johnson MT. Postoperative positioning following RD surgery. Retinal Physician. 2013;10:25-29. Accessed November 18, 2022. https://www.retinalphysician.com/issues/2013/july-aug/postoperative-posi...
LinkOut - more resources
Full Text Sources